SCHEMBL7110545

SCHEMBL7110545

[C]1=CC=CC2SC3C=CC=CC3C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL450862 0.74
SCHEMBL2803767 0.64
SCHEMBL1008893 0.62
Hydrochloric Acid SCHEMBL28458236 0.61
SCHEMBL7752905 0.60
SCHEMBL1386194 0.56
SCHEMBL8781808 0.55
SCHEMBL8781723 0.55
SCHEMBL1717410 0.53
SCHEMBL4754663 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220040318-A1 PRIMARY AMINE COMPOUND OR SECONDARY AMINE COMPOUND-ACIDIC POLYSACCHARIDE CONJUGATE AND PRODUCTION METHOD THEREFOR SEIKAGAKU CORPORATION (JP) 2022-02-10 US disclosed
US-20210015933-A1 BIOACTIVE CARBOXYLIC ACID TYPE COMPOUND-POLYMER CONJUGATE, AND METHOD FOR MANUFACTURING THE SAME SEIKAGAKU CORPORATION (JP) 2021-01-21 US disclosed
US-20200138964-A1 TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR SEIKAGAKU CORPORATION (JP) 2020-05-07 US disclosed
WO-2020067507-A1 PRIMARY AMINE COMPOUND- OR SECONDARY AMINE COMPOUND-ACIDIC POLYSACCHARIDE CONJUGATE, AND METHOD FOR PRODUCING SAME 生化学工業株式会社 2020-04-02 WO disclosed
WO-2019189876-A1 (CARBOXYLIC ACID-TYPE COMPOUND)-POLYMER CONJUGATE HAVING BIOLOGICAL ACTIVITY, AND METHOD FOR PRODUCING SAME 生化学工業株式会社 2019-10-03 WO disclosed
EP-1016660-B1 COMPOUNDS HAVING 2.2.1]BICYCLO SKELETON SHIONOGI & CO (JP) 2003-10-29 EP disclosed
US-6225336-B1 FOR THERAPY OF SYSTEMIC MASTOCYTOSIS AND DISORDER OF SYSTEMIC MAST CELL ACTIVATION AS WELL AS TRACHEAL CONTRACTION, ASTHMA, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, URTICARIA, ISCHEMIC REPERFUSION INJURY, AND INFLAMMATION SHIONOGI & CO., LTD. (JP) 2001-05-01 US disclosed
EP-1016660-A1 COMPOUNDS HAVING 2.2.1]BICYCLO SKELETON SHIONOGI & CO., LTD. (JP) 2000-07-05 EP disclosed